These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11926699)

  • 1. Dipyridamole may be used safely in patients with ischaemic heart disease.
    Humphreys DM; Street J; Schumacher H; Bertrand-Hardy JM; Palluk R
    Int J Clin Pract; 2002 Mar; 56(2):121-7. PubMed ID: 11926699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ
    Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac safety in the European Stroke Prevention Study 2 (ESPS2).
    Diener HC; Darius H; Bertrand-Hardy JM; Humphreys M;
    Int J Clin Pract; 2001 Apr; 55(3):162-3. PubMed ID: 11351768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke.
    Thijs V; Lemmens R; Fieuws S
    Eur Heart J; 2008 May; 29(9):1086-92. PubMed ID: 18349026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet agents and randomized trials.
    Diener HC
    Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipyridamole-associated headache in stroke patients--interindividual differences?
    Lökk J
    Eur Neurol; 2009; 62(2):109-13. PubMed ID: 19521087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?
    Rouhl RP; Lodder J
    Expert Rev Neurother; 2008 Nov; 8(11):1661-5. PubMed ID: 18986236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC
    Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MATCH results: implications for the internist.
    Lutsep HL
    Am J Med; 2006 Jun; 119(6):526.e1-7. PubMed ID: 16750967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
    Gebel JM
    J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
    Smith EE; Cannon CP; Murphy S; Feske SK; Schwamm LH
    Am Heart J; 2006 Feb; 151(2):338-44. PubMed ID: 16442896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole.
    Weyrich AS; Skalabrin EJ; Kraiss LW
    Am J Ther; 2009; 16(2):164-70. PubMed ID: 19300042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of aspirin plus extended-release dipyridamole in preventing recurrent stroke in high-risk populations.
    Sacco RL; Sivenius J; Diener HC
    Arch Neurol; 2005 Mar; 62(3):403-8. PubMed ID: 15767505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of fixed-dose aspirin-extended-release dipyridamole in patients with ischemic heart disease.
    Crown N; Mysak T
    Am J Health Syst Pharm; 2010 May; 67(9):728-33. PubMed ID: 20410547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.
    Hennekens CH; Sacks FM; Tonkin A; Jukema JW; Byington RP; Pitt B; Berry DA; Berry SM; Ford NF; Walker AJ; Natarajan K; Sheng-Lin C; Fiedorek FT; Belder R
    Arch Intern Med; 2004 Jan; 164(1):40-4. PubMed ID: 14718320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.